Panagiotis Zis1, Dasappaiah Ganesh Rao2, Nigel Hoggard3, Ptolemaios Georgios Sarrigiannis2, Marios Hadjivassiliou2. 1. Academic Department of Neurosciences, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England. takiszis@gmail.com. 2. Academic Department of Neurosciences, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England. 3. Department of Neuroradiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England.
Abstract
BACKGROUND: Myelin-associated glycoprotein (MAG) is a glycoprotein specific to Schwann cells. Schwann cells produce myelin for nerve cells in the peripheral nervous system. MAG also plays a role in the central nervous system (CNS) by maintaining myelin integrity and inhibiting axonal regeneration from cerebellar neurons. There is a well-established link between distal demyelinating neuropathy and anti-MAG antibodies in patients with monoclonal gammopathy of unknown significance. We describe a series of five patients with anti-MAG antibodies with evidence of cerebellar rather than just sensory ataxia and our experience of treatment with rituximab. METHODS: Cerebellar ataxia was clinically suspected and confirmed using magnetic resonance spectroscopy (MRS) of the cerebellum. All patients underwent detailed nerve conduction studies. RESULTS: Four patients were males. The ages ranged from 64 to 82 years. All patients were anti-MAG positive and also had IgM monoclonal gammopathy. Four patients had neuropathy, whilst one had no evidence of neuropathy. All patients were treated with rituximab and showed improvement in the MRS parameters of the cerebellum. CONCLUSION: Anti-MAG antibodies might be involved in the pathogenesis of idiopathic sporadic ataxias, even in the absence of peripheral neuropathy. Rituximab seems to be a promising therapeutic intervention for those cases.
BACKGROUND:Myelin-associated glycoprotein (MAG) is a glycoprotein specific to Schwann cells. Schwann cells produce myelin for nerve cells in the peripheral nervous system. MAG also plays a role in the central nervous system (CNS) by maintaining myelin integrity and inhibiting axonal regeneration from cerebellar neurons. There is a well-established link between distal demyelinating neuropathy and anti-MAG antibodies in patients with monoclonal gammopathy of unknown significance. We describe a series of five patients with anti-MAG antibodies with evidence of cerebellar rather than just sensory ataxia and our experience of treatment with rituximab. METHODS:Cerebellar ataxia was clinically suspected and confirmed using magnetic resonance spectroscopy (MRS) of the cerebellum. All patients underwent detailed nerve conduction studies. RESULTS: Four patients were males. The ages ranged from 64 to 82 years. All patients were anti-MAG positive and also had IgM monoclonal gammopathy. Four patients had neuropathy, whilst one had no evidence of neuropathy. All patients were treated with rituximab and showed improvement in the MRS parameters of the cerebellum. CONCLUSION: Anti-MAG antibodies might be involved in the pathogenesis of idiopathic sporadic ataxias, even in the absence of peripheral neuropathy. Rituximab seems to be a promising therapeutic intervention for those cases.
Authors: Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard Journal: Postgrad Med J Date: 2012-09-26 Impact factor: 2.401
Authors: Leonardo Baldarçara; Stuart Currie; M Hadjivassiliou; Nigel Hoggard; Allison Jack; Andrea P Jackowski; Mario Mascalchi; Cecilia Parazzini; Kathrin Reetz; Andrea Righini; Jörg B Schulz; Alessandra Vella; Sara Jane Webb; Christophe Habas Journal: Cerebellum Date: 2015-04 Impact factor: 3.847
Authors: Marios Hadjivassiliou; Richard A Grünewald; David S Sanders; Priya Shanmugarajah; Nigel Hoggard Journal: Neurology Date: 2017-07-19 Impact factor: 9.910
Authors: M Hadjivassiliou; J Martindale; P Shanmugarajah; R A Grünewald; P G Sarrigiannis; N Beauchamp; K Garrard; R Warburton; D S Sanders; D Friend; S Duty; J Taylor; N Hoggard Journal: J Neurol Neurosurg Psychiatry Date: 2016-12-13 Impact factor: 10.154
Authors: Priya D Shanmugarajah; Nigel Hoggard; Stuart Currie; Daniel P Aeschlimann; Pascale C Aeschlimann; Dermot C Gleeson; Mohammed Karajeh; Nicola Woodroofe; Richard A Grünewald; Marios Hadjivassiliou Journal: Cerebellum Ataxias Date: 2016-10-03
Authors: Panagiotis Zis; Mary M Reilly; Dasappaiah G Rao; Pedro Tomaselli; Alex M Rossor; Marios Hadjivassiliou Journal: J Peripher Nerv Syst Date: 2017-09 Impact factor: 3.494